{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023971","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.896648+00:00","generated_at":"2026-05-17T12:59:34.179182+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Daré Bioscience Q2 2025: Cash $5.0M, Sildenafil Cream launch on track for Q4 2025, Ovaprene DSMB positive","bullets":["Cash of $5.0M at June 30; working capital deficit $12.6M; raised ~$17.6M net from ATM and $6M grant post-quarter.","G&A $2.4M, R&D $1.4M (down 71% YoY) reflecting increased contra R&D from grants.","DARE to PLAY Sildenafil Cream on track for Q4 2025 launch via 503B compounding, targeting near-term revenue.","Ovaprene Phase 3 DSMB recommended continuation no new safety concerns; interim pregnancy rate consistent.","DARE-HRT1 monthly ring pursuing 503B compounding for late 2026 alongside FDA pathway."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023971","json":"https://secwatch.observer/filing/0001641172-25-023971.json","markdown":"https://secwatch.observer/filing/0001641172-25-023971.md","text":"https://secwatch.observer/filing/0001641172-25-023971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225023971/0001641172-25-023971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225023971/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:59:34.179182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}